Table 3.
Molecular formulas, half-lives and dosing schedules for BCR-ABL1 TKIs.
TKI | Structural Formula | Half Life | Recommended Starting Dose |
---|---|---|---|
Imatinib |
![]() |
18 hours | 400 mg daily |
Dasatinib |
![]() |
3–5 hours | 100 mg once daily |
Nilotinib |
![]() |
17 hours | 300 mg twice daily |
Ponatinib |
![]() |
12–66 hours | 45 mg once daily |
Bosutinib |
![]() |
22 hours (oral) | 400 mg once daily |
Asciminib |
![]() |
8 hours | 40 mg BID (estimated) |